Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-23-071929

Director acquired 4,320 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

AZAB MOHAMMAD · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-19 Exercise or conversion : show line 1 in the form +823 $9.85 $8,107 70,728 D
2023-12-19 Exercise or conversion : show line 2 in the form +3,497 $9.85 $34,445 74,225 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-12-19 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −823 0 D
2023-12-19 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −3,497 0 D
Loading xslF345X05/ownership.xml…